The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vagus Nerve Stimulation (VNS) Market Research Report 2025
Synopsis
Vagal nerve stimulation or vagus nerve stimulation (VNS) is a treatment method that involves delivering electrical impulses to the vagus nerve. Vegas nerve acts as a translator between gut and brain. Gut uses the vagus nerve like a walkie-talkie and translates signals via electric impulses, which called action potentials. VNS treatment is used for certain types of intractable epilepsy, depression, and others. In most common cases, overstimulation of the vagus nerve causes fainting. Vagus nerve stimulation is a procedure, which involves implantation of a device that stimulates the vagus nerve with electrical impulses. This device is normally implanted under the skin below the patient’s clavicle. Lead wires from the generator are excavated up to the patient’s neck and wrapped around the left vagus nerve at the carotid sheath, where it delivers electrical impulses to the nerve. After successfully implanted, the generator sends electric impulses to the vagus nerve at a regular intervals.
The global Vagus Nerve Stimulation (VNS) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Increasing prevalence of neurological disorders, increasing investment of biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drives the growth of the market. Moreover, favorable reimbursement policies, increased application and significant investments in development of new technologies for the treatment of epilepsy, and other cardiac indications will fuel the market growth during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Vagus Nerve Stimulation (VNS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vagus Nerve Stimulation (VNS).
Report Scope
The Vagus Nerve Stimulation (VNS) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vagus Nerve Stimulation (VNS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vagus Nerve Stimulation (VNS) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LivaNova
ReShape Lifesciences
ElectroCore Medical
Boston Scientific
Cyberonics
NeuroMetrix
ImThera Medical
Inspire Medical Systems
Segment by Type
Implantable VNS Devices
External VNS Devices
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vagus Nerve Stimulation (VNS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vagus Nerve Stimulation (VNS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Vagal nerve stimulation or vagus nerve stimulation (VNS) is a treatment method that involves delivering electrical impulses to the vagus nerve. Vegas nerve acts as a translator between gut and brain. Gut uses the vagus nerve like a walkie-talkie and translates signals via electric impulses, which called action potentials. VNS treatment is used for certain types of intractable epilepsy, depression, and others. In most common cases, overstimulation of the vagus nerve causes fainting. Vagus nerve stimulation is a procedure, which involves implantation of a device that stimulates the vagus nerve with electrical impulses. This device is normally implanted under the skin below the patient’s clavicle. Lead wires from the generator are excavated up to the patient’s neck and wrapped around the left vagus nerve at the carotid sheath, where it delivers electrical impulses to the nerve. After successfully implanted, the generator sends electric impulses to the vagus nerve at a regular intervals.
The global Vagus Nerve Stimulation (VNS) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Increasing prevalence of neurological disorders, increasing investment of biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drives the growth of the market. Moreover, favorable reimbursement policies, increased application and significant investments in development of new technologies for the treatment of epilepsy, and other cardiac indications will fuel the market growth during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Vagus Nerve Stimulation (VNS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vagus Nerve Stimulation (VNS).
Report Scope
The Vagus Nerve Stimulation (VNS) market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vagus Nerve Stimulation (VNS) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vagus Nerve Stimulation (VNS) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
LivaNova
ReShape Lifesciences
ElectroCore Medical
Boston Scientific
Cyberonics
NeuroMetrix
ImThera Medical
Inspire Medical Systems
Segment by Type
Implantable VNS Devices
External VNS Devices
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vagus Nerve Stimulation (VNS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vagus Nerve Stimulation (VNS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vagus Nerve Stimulation (VNS) Market Overview
1.1 Product Overview and Scope of Vagus Nerve Stimulation (VNS)
1.2 Vagus Nerve Stimulation (VNS) Segment by Type
1.2.1 Global Vagus Nerve Stimulation (VNS) Market Value Comparison by Type (2024-2030)
1.2.2 Implantable VNS Devices
1.2.3 External VNS Devices
1.2.4 Others
1.3 Vagus Nerve Stimulation (VNS) Segment by Application
1.3.1 Global Vagus Nerve Stimulation (VNS) Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Vagus Nerve Stimulation (VNS) Market Size Estimates and Forecasts
1.4.1 Global Vagus Nerve Stimulation (VNS) Revenue 2019-2030
1.4.2 Global Vagus Nerve Stimulation (VNS) Sales 2019-2030
1.4.3 Global Vagus Nerve Stimulation (VNS) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vagus Nerve Stimulation (VNS) Market Competition by Manufacturers
2.1 Global Vagus Nerve Stimulation (VNS) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vagus Nerve Stimulation (VNS) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vagus Nerve Stimulation (VNS) Average Price by Manufacturers (2019-2024)
2.4 Global Vagus Nerve Stimulation (VNS) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vagus Nerve Stimulation (VNS), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vagus Nerve Stimulation (VNS), Product Type & Application
2.7 Vagus Nerve Stimulation (VNS) Market Competitive Situation and Trends
2.7.1 Vagus Nerve Stimulation (VNS) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vagus Nerve Stimulation (VNS) Players Market Share by Revenue
2.7.3 Global Vagus Nerve Stimulation (VNS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vagus Nerve Stimulation (VNS) Retrospective Market Scenario by Region
3.1 Global Vagus Nerve Stimulation (VNS) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vagus Nerve Stimulation (VNS) Global Vagus Nerve Stimulation (VNS) Sales by Region: 2019-2030
3.2.1 Global Vagus Nerve Stimulation (VNS) Sales by Region: 2019-2024
3.2.2 Global Vagus Nerve Stimulation (VNS) Sales by Region: 2025-2030
3.3 Global Vagus Nerve Stimulation (VNS) Global Vagus Nerve Stimulation (VNS) Revenue by Region: 2019-2030
3.3.1 Global Vagus Nerve Stimulation (VNS) Revenue by Region: 2019-2024
3.3.2 Global Vagus Nerve Stimulation (VNS) Revenue by Region: 2025-2030
3.4 North America Vagus Nerve Stimulation (VNS) Market Facts & Figures by Country
3.4.1 North America Vagus Nerve Stimulation (VNS) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vagus Nerve Stimulation (VNS) Sales by Country (2019-2030)
3.4.3 North America Vagus Nerve Stimulation (VNS) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vagus Nerve Stimulation (VNS) Market Facts & Figures by Country
3.5.1 Europe Vagus Nerve Stimulation (VNS) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vagus Nerve Stimulation (VNS) Sales by Country (2019-2030)
3.5.3 Europe Vagus Nerve Stimulation (VNS) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vagus Nerve Stimulation (VNS) Market Facts & Figures by Country
3.6.1 Asia Pacific Vagus Nerve Stimulation (VNS) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vagus Nerve Stimulation (VNS) Sales by Country (2019-2030)
3.6.3 Asia Pacific Vagus Nerve Stimulation (VNS) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vagus Nerve Stimulation (VNS) Market Facts & Figures by Country
3.7.1 Latin America Vagus Nerve Stimulation (VNS) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vagus Nerve Stimulation (VNS) Sales by Country (2019-2030)
3.7.3 Latin America Vagus Nerve Stimulation (VNS) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vagus Nerve Stimulation (VNS) Market Facts & Figures by Country
3.8.1 Middle East and Africa Vagus Nerve Stimulation (VNS) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vagus Nerve Stimulation (VNS) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vagus Nerve Stimulation (VNS) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vagus Nerve Stimulation (VNS) Sales by Type (2019-2030)
4.1.1 Global Vagus Nerve Stimulation (VNS) Sales by Type (2019-2024)
4.1.2 Global Vagus Nerve Stimulation (VNS) Sales by Type (2025-2030)
4.1.3 Global Vagus Nerve Stimulation (VNS) Sales Market Share by Type (2019-2030)
4.2 Global Vagus Nerve Stimulation (VNS) Revenue by Type (2019-2030)
4.2.1 Global Vagus Nerve Stimulation (VNS) Revenue by Type (2019-2024)
4.2.2 Global Vagus Nerve Stimulation (VNS) Revenue by Type (2025-2030)
4.2.3 Global Vagus Nerve Stimulation (VNS) Revenue Market Share by Type (2019-2030)
4.3 Global Vagus Nerve Stimulation (VNS) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vagus Nerve Stimulation (VNS) Sales by Application (2019-2030)
5.1.1 Global Vagus Nerve Stimulation (VNS) Sales by Application (2019-2024)
5.1.2 Global Vagus Nerve Stimulation (VNS) Sales by Application (2025-2030)
5.1.3 Global Vagus Nerve Stimulation (VNS) Sales Market Share by Application (2019-2030)
5.2 Global Vagus Nerve Stimulation (VNS) Revenue by Application (2019-2030)
5.2.1 Global Vagus Nerve Stimulation (VNS) Revenue by Application (2019-2024)
5.2.2 Global Vagus Nerve Stimulation (VNS) Revenue by Application (2025-2030)
5.2.3 Global Vagus Nerve Stimulation (VNS) Revenue Market Share by Application (2019-2030)
5.3 Global Vagus Nerve Stimulation (VNS) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 LivaNova
6.1.1 LivaNova Corporation Information
6.1.2 LivaNova Description and Business Overview
6.1.3 LivaNova Vagus Nerve Stimulation (VNS) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 LivaNova Vagus Nerve Stimulation (VNS) Product Portfolio
6.1.5 LivaNova Recent Developments/Updates
6.2 ReShape Lifesciences
6.2.1 ReShape Lifesciences Corporation Information
6.2.2 ReShape Lifesciences Description and Business Overview
6.2.3 ReShape Lifesciences Vagus Nerve Stimulation (VNS) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ReShape Lifesciences Vagus Nerve Stimulation (VNS) Product Portfolio
6.2.5 ReShape Lifesciences Recent Developments/Updates
6.3 ElectroCore Medical
6.3.1 ElectroCore Medical Corporation Information
6.3.2 ElectroCore Medical Description and Business Overview
6.3.3 ElectroCore Medical Vagus Nerve Stimulation (VNS) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 ElectroCore Medical Vagus Nerve Stimulation (VNS) Product Portfolio
6.3.5 ElectroCore Medical Recent Developments/Updates
6.4 Boston Scientific
6.4.1 Boston Scientific Corporation Information
6.4.2 Boston Scientific Description and Business Overview
6.4.3 Boston Scientific Vagus Nerve Stimulation (VNS) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boston Scientific Vagus Nerve Stimulation (VNS) Product Portfolio
6.4.5 Boston Scientific Recent Developments/Updates
6.5 Cyberonics
6.5.1 Cyberonics Corporation Information
6.5.2 Cyberonics Description and Business Overview
6.5.3 Cyberonics Vagus Nerve Stimulation (VNS) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cyberonics Vagus Nerve Stimulation (VNS) Product Portfolio
6.5.5 Cyberonics Recent Developments/Updates
6.6 NeuroMetrix
6.6.1 NeuroMetrix Corporation Information
6.6.2 NeuroMetrix Description and Business Overview
6.6.3 NeuroMetrix Vagus Nerve Stimulation (VNS) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 NeuroMetrix Vagus Nerve Stimulation (VNS) Product Portfolio
6.6.5 NeuroMetrix Recent Developments/Updates
6.7 ImThera Medical
6.6.1 ImThera Medical Corporation Information
6.6.2 ImThera Medical Description and Business Overview
6.6.3 ImThera Medical Vagus Nerve Stimulation (VNS) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ImThera Medical Vagus Nerve Stimulation (VNS) Product Portfolio
6.7.5 ImThera Medical Recent Developments/Updates
6.8 Inspire Medical Systems
6.8.1 Inspire Medical Systems Corporation Information
6.8.2 Inspire Medical Systems Description and Business Overview
6.8.3 Inspire Medical Systems Vagus Nerve Stimulation (VNS) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Inspire Medical Systems Vagus Nerve Stimulation (VNS) Product Portfolio
6.8.5 Inspire Medical Systems Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vagus Nerve Stimulation (VNS) Industry Chain Analysis
7.2 Vagus Nerve Stimulation (VNS) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vagus Nerve Stimulation (VNS) Production Mode & Process
7.4 Vagus Nerve Stimulation (VNS) Sales and Marketing
7.4.1 Vagus Nerve Stimulation (VNS) Sales Channels
7.4.2 Vagus Nerve Stimulation (VNS) Distributors
7.5 Vagus Nerve Stimulation (VNS) Customers
8 Vagus Nerve Stimulation (VNS) Market Dynamics
8.1 Vagus Nerve Stimulation (VNS) Industry Trends
8.2 Vagus Nerve Stimulation (VNS) Market Drivers
8.3 Vagus Nerve Stimulation (VNS) Market Challenges
8.4 Vagus Nerve Stimulation (VNS) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
